ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,430Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 226

$704K Total Retail Price of All Prescriptions

Rank: 27 out of 226

632 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

2% of this provider’s 632 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 7,709 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $106 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
ALLOPURINOL 395 333 1 11
LEVOTHYROXINE SODIUM 390 338 2 18
METOPROLOL TARTRATE 364 294 3 9
FUROSEMIDE 350 303 4 2
POTASSIUM CHLORIDE 302 237 5 25
HYDROCHLOROTHIAZIDE 294 274 6 20
PRAVASTATIN SODIUM 263 222 7 30
AMLODIPINE BESYLATE 243 206 8 1
HYDRALAZINE HCL 231 194 9 5
NIFEDIAC CC 225 208 10 10 62
LISINOPRIL 224 185 11 3
LOSARTAN POTASSIUM 209 203 12 13
CARVEDILOL 181 127 13 7
CLONIDINE HCL 173 130 14 12
TRAMADOL HCL 165 152 15 28
SIMVASTATIN 158 124 16 10
SENSIPAR 146 60 17 6
CRESTOR 145 127 18 42
ATENOLOL 133 88 19 32
PANTOPRAZOLE SODIUM 133 101 19 38
OMEPRAZOLE 133 98 19 16
ATORVASTATIN CALCIUM 132 113 22 27
BENAZEPRIL HCL 130 107 23 49
NIFEDIPINE ER 129 93 24 15
DIOVAN 124 116 25 23
BENICAR 120 98 26 87
ZOLPIDEM TARTRATE 117 85 27 29
LOVASTATIN 107 83 28 91
CALCIUM ACETATE 103 72 29 14
METOPROLOL SUCCINATE 101 93 30 22
GABAPENTIN 92 51 31 21
METFORMIN HCL 89 80 32 39
SYNTHROID 86 64 33 74
AZITHROMYCIN 78 65 34 78
CALCITRIOL 74 69 35 8
CLOPIDOGREL 67 60 36 44
ALENDRONATE SODIUM 67 57 36 72
ZETIA 66 66 38 73
CEPHALEXIN 66 59 38 124
NEXIUM 64 33 40 26
ISOSORBIDE MONONITRATE ER 64 62 40 45
RENVELA 61 18 42 4
GEMFIBROZIL 60 45 43 194
GLIPIZIDE ER 59 58 44 113
VYTORIN 56 53 45 197
DOXAZOSIN MESYLATE 54 54 46 19
CITALOPRAM HBR 51 48 47 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 10, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.